Article Text

PDF

Alpha interferon treatment of chronic hepatitis C in beta-thalassaemia.
  1. V Di Marco,
  2. O Lo Iacono,
  3. M Capra,
  4. S Grutta,
  5. C Ciaccio,
  6. C Gerardi,
  7. A Maggio,
  8. D Renda,
  9. P Almasio,
  10. R Pisa
  1. Clinica Medica R and Anat Patologica, Ospedale Cervello, Palermo, Sicily, Italy.

    Abstract

    In this open, pilot study, interferon (IFN) alpha-2b seemed effective in the treatment of hepatitis C virus (HCV) infection in patients with beta-thalassaemia. In seven of nine patients who completed the study alanine aminotransferase activities returned to normal, and a completely stable response 24 months after treatment was seen in five. Liver biopsy specimen showed a clear reduction in portal, periportal, and lobular necroinflammation in all five cases. Three patients stopped treatment early because of side effects.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.